date:Oct 11, 2018
extremely pleased this new research clearly indicates a viable new option to manage sarcopenia. This study is the first of its kind that shows such a significant improvement in muscular strength and endurance using AstaMed MYO along with exercise that can make a difference in the lives of millions of aging Americans facing the debilitating effects of sarcopenia, says Dan Mueller, General Manager of AstaMed.
The nutritional intervention product AstaMed MYO is produced in a FDA-regulated facilit